|
Alydar Pharmaceuticals has developed its infochemicals-based Pheromics™ Library and Database which are available for strategic partnering with
pharmaceutical and biotech companies.
Alydar envisions that infochemicals will be used for the treatment of major
human diseases, and disorders, including cardiovascular, neurological,
psychiatric, cancer, and wound healing. Alydar has already demonstrated
activity of infochemicals in disease-specific in
vitro and in vivo models
for cancer and cardiovascular disease.
|
 |
